000040851 000__ 03019nam\a2200349\a\4500
000040851 001__ 40851
000040851 003__ SzGeWIPO
000040851 005__ 20231124105959.0
000040851 006__ m\\\\\o\\d\\\\\\\\
000040851 007__ cr\un|||||||||
000040851 008__ 091104s2010\\\\enk\\\\\ob\\\\001\0\eng\d
000040851 010__ $$a2009940738
000040851 020__ $$a9781849808149$$qeBook
000040851 020__ $$z9781848442061$$qPrint
000040851 035__ $$aeep9781849808149
000040851 040__ $$aSzGeWIPO$$beng$$cSzGeWIPO$$erda
000040851 041__ $$aeng
000040851 043__ $$aa-cc---
000040851 050_4 $$aKNQ1194$$b.L55 2010
000040851 1001_ $$aLi, Yahong.
000040851 24510 $$aImitation to Innovation in China:$$bThe Role of Patents in Biotechnology and Pharmaceutical Industries.
000040851 260__ $$aCheltenham ;$$aNorthampton, Mass. :$$bEdward Elgar,$$c2010.
000040851 300__ $$a208 pages.
000040851 4901_ $$aNew Horizons in Intellectual Property series
000040851 504__ $$aIncludes bibliographical references and index.
000040851 5050_ $$aForeword -- Preface -- 1. The Role of Patents in Innovation: Introduction -- 2. An Overview of China’s Biotechnology and Pharmaceutical Industries -- 3. Innovation Capacity and Infrastructure -- 4. Models of R&D and Commercialization -- 5. The Role of Patents in Innovation: Case Studies -- 6. Patentable Biotechnology and Pharmaceutical Inventions -- 7. Patentability of Biotechnology and Pharmaceutical Inventions -- 8. Patent Rights in Biotechnology and Pharmaceutical Inventions -- 9. The Role of Patents in Innovation: Further Reflections -- Index
000040851 520__ $$aFollowing decades in which China’s approach to technology has been to imitate, the country is now transforming itself to become innovation-oriented. This pioneering study examines whether patents play a similar role in promoting innovation in China as they do in the West, exploring the interplay between patents and China’s biotechnology and pharmaceutical industries in particular.  The author argues for a stronger patent regime based on an extensive review of the technological capacity, R&D models, patent filings and litigations, and issues in patent law, which involve China’s biotechnology and pharmaceutical industries. By comparing China with other developing countries and analyzing China’s uniqueness in terms of its development stage, technological capacity and the strengths and weaknesses in its patent system, Yahong Li concludes that China is distinguished from the prevailing view that patents play a limited role in innovation in developing countries. The book also discusses whether and how patents can promote innovation in China’s biotechnology and pharmaceutical industries, based on the study of market scale, R&D capacity, innovation model and patent legislation and cases.  This comprehensively researched book will be invaluable to multinational biotechnology and pharmaceutical companies either doing business or planning to do business in China. Practitioners and policymakers as well as academics and students specializing in IP law, economics and technology should also not be without this eloquent book.
000040851 650_0 $$aPatent laws and legislation$$zChina.
000040851 650_0 $$aBiotechnology industries$$xLaw and legislation$$zChina.
000040851 650_0 $$aPharmacy$$xLaw and legislation$$zChina.
000040851 655_7 $$aElectronic books.$$2lcsh
000040851 85641 $$uhttps://www.elgaronline.com/view/9781848442061.xml$$yView eBook
000040851 903__ $$aNew Horizons in Intellectual Property series
000040851 904__ $$aBook
000040851 980__ $$aOS